Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease

Affiliations

¹ 1 Harvard Pilgrim Health Care Institute and Harvard Medical School Boston, Massachusetts.
² 2 University of Pennsylvania Philadelphia, Pennsylvania.

Comment

Ann Chen Wu et al. Am J Respir Crit Care Med. 2019.

. 2019 Jun 15;199(12):1579.

doi: 10.1164/rccm.201902-0432LE.

¹ 1 Harvard Pilgrim Health Care Institute and Harvard Medical School Boston, Massachusetts.
² 2 University of Pennsylvania Philadelphia, Pennsylvania.

No abstract available

Comment on

Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE. Wu AC, et al. Am J Respir Crit Care Med. 2018 Dec 15;198(12):e116-e136. doi: 10.1164/rccm.201810-1895ST. Am J Respir Crit Care Med. 2018. PMID: 30640517 Free PMC article.
Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease.
Mahler DA. Mahler DA. Am J Respir Crit Care Med. 2019 Jun 15;199(12):1577-1579. doi: 10.1164/rccm.201901-0005LE. Am J Respir Crit Care Med. 2019. PMID: 30892057 Free PMC article. No abstract available.

1. Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, et al. Current status and future opportunities in lung precision medicine research with a focus on biomarkers: an American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement. Am J Respir Crit Care Med. 2018;198:e116–e136. - PMC - PubMed